The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2025
Filed:
Apr. 28, 2023
Applicant:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Inventors:
Jie Dai, Yorktown Heights, NY (US);
Maria del Pilar Molina-Portela, Bronx, NY (US);
Ella Ioffe, Bronx, NY (US);
Markus Mohrs, Pleasantville, NY (US);
Assignee:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 1/22 (2006.01); C07K 14/54 (2006.01); C07K 16/42 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/5428 (2013.01); A61K 38/2066 (2013.01); A61K 47/68 (2017.08); A61K 47/6889 (2017.08); A61P 35/00 (2018.01); C07K 1/22 (2013.01); C07K 16/42 (2013.01); A61K 38/00 (2013.01); C07K 2317/524 (2013.01); C07K 2317/526 (2013.01); C07K 2317/53 (2013.01); C07K 2319/30 (2013.01);
Abstract
The present disclosure relates to IL10 agonists with improved anti-tumor therapeutic efficacy and uses thereof. Certain IL10 agonists disclosed herein comprise an IgG Fc domain, a linker moiety, and an IL10 moiety.
Quick Actions:
Dai, Jie. (2025). Il10 agonists and methods of use thereof (U.S. Patent No. 12187772). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12187772
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile